Evidence map›Paper›PMID 30059496›Full record

ArticlePLoS neglected tropical diseases2018

Differing epidemiological dynamics of Chikungunya virus in the Americas during the 2014-2015 epidemic.

Yi Tan, Brett E Pickett, Susmita Shrivastava, Lionel Gresh, Angel Balmaseda, Paolo Amedeo, Lihui Hu, Vinita Puri, Nadia B Fedorova, Rebecca A Halpin and 9 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Evolution and epidemiologic dynamics of dengue virus in Nicaragua during the emergence of chikungunya and Zika viruses.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021
    Article
  11. Rediscovering the chikungunya virusBiomedica : revista del Instituto Nacional de Salud · 2021
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Yi TanJ. Craig Venter Institute, Rockville, Maryland, United States of America.
Brett E PickettJ. Craig Venter Institute, Rockville, Maryland, United States of America.
Susmita ShrivastavaJ. Craig Venter Institute, Rockville, Maryland, United States of America.ORCID 0000-0001-8252-2926
Lionel GreshSustainable Sciences Institute, Managua, Nicaragua.ORCID 0000-0002-2333-1748
Angel BalmasedaLaboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua.
Paolo AmedeoJ. Craig Venter Institute, Rockville, Maryland, United States of America.
Lihui HuJ. Craig Venter Institute, Rockville, Maryland, United States of America.
Vinita PuriJ. Craig Venter Institute, Rockville, Maryland, United States of America.
Nadia B FedorovaJ. Craig Venter Institute, Rockville, Maryland, United States of America.
Rebecca A HalpinJ. Craig Venter Institute, Rockville, Maryland, United States of America.
Matthew P LaPointeJ. Craig Venter Institute, Rockville, Maryland, United States of America.ORCID 0000-0002-7859-2160
Marshall R ConeFlorida Department of Health, Bureau of Public Health Laboratories, Tampa, Florida, United States of America.
Lea Heberlein-LarsonFlorida Department of Health, Bureau of Public Health Laboratories, Tampa, Florida, United States of America.
Laura D KramerWadsworth Center, New York State Department of Health, Albany, New York, United States of America.
Alexander T CiotaWadsworth Center, New York State Department of Health, Albany, New York, United States of America.
Aubree GordonDepartment of Epidemiology, University of Michigan, Ann Arbor, Michigan, United States of America.
Reed S ShabmanJ. Craig Venter Institute, Rockville, Maryland, United States of America.
Suman R DasJ. Craig Venter Institute, Rockville, Maryland, United States of America.ORCID 0000-0003-2496-9724
Eva HarrisDivision of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, California, United States of America.
J. Craig Venter Institute · USFlorida Department of Health · USNew York State Department of Health · USNational Autonomous University of Nicaragua · NISustainable Sciences Institute · USUniversity of California, Berkeley · USUniversity of Michigan · US

Funding

Project 3 - Ex vivo immune profiling of dengue viruses and vaccinesU19AI118610 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KASARSKIS, ANDREW · 2015 to 2021
$46.6M
T Cell Responses Following DENV Natural Infections and Live-Attenuated Dengue Virus VaccinationP01AI106695 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI Eva Harris · 2015 to 2026
$34.1M
The J. Craig Venter Institute Genome Center for Infectious DiseasesU19AI110819 · NIAID · J. CRAIG VENTER INSTITUTE, INC. · PI TAN, GENE · 2014 to 2018
$29.7M
Tennessee CFAR: Implementation of Culturally Responsive Trauma-Informed Care with Youth with HIV in Memphis, TNP30AI110527 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI John Koethe · 2015 to 2026
$27.5M
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)U19AI168631 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ana Fernandez-Sesma, Viviana A Simon · 2022 to 2026
$14.4M
Epidemiological, Clinical & Immunological Studies of Zika, dengue and chikungunyaR01AI099631 · NIAID · SUSTAINABLE SCIENCES INSTITUTE · PI BALMASEDA, ANGEL LAZARO · 2012 to 2021
$1.8M
NIAID NIH HHS P01 AI106695NIAID NIH HHS P30 AI110527NIAID NIH HHS R01 AI099631NIAID NIH HHS U19 AI110819NIAID NIH HHS U19 AI118610NIAID NIH HHS U19 AI168631
6 · The paper itself

Abstract

Chikungunya virus (CHIKV) has been detected sporadically since the 1950s and includes three distinct co-circulating genotypes. In late 2013, the Asian genotype of CHIKV was responsible for the Caribbean outbreak (CO) that rapidly became an epidemic throughout the Americas. There is a limited understanding of the molecular evolution of CHIKV in the Americas during this epidemic. We sequenced 185 complete CHIKV genomes collected mainly from Nicaragua in Central America and Florida in the United States during the 2014-2015 Caribbean/Americas epidemic. Our comprehensive phylogenetic analyses estimated the epidemic history of the Asian genotype and the recent Caribbean outbreak (CO) clade, revealed considerable genetic diversity within the CO clade, and described different epidemiological dynamics of CHIKV in the Americas. Specifically, we identified multiple introductions in both Nicaragua and Florida, with rapid local spread of viruses in Nicaragua but limited autochthonous transmission in Florida in the US. Our phylogenetic analysis also showed phylogeographic clustering of the CO clade. In addition, we identified the significant amino acid substitutions that were observed across the entire Asian genotype during its evolution and examined amino acid changes that were specific to the CO clade. Deep sequencing analysis identified specific minor variants present in clinical specimens below-consensus levels. Finally, we investigated the association between viral phylogeny and geographic/clinical metadata in Nicaragua. To date, this study represents the largest single collection of CHIKV complete genomes during the Caribbean/Americas epidemic and significantly expands our understanding of the emergence and evolution of CHIKV CO clade in the Americas.

Indexed as

AdolescentAsiaChikungunya FeverChikungunya virusChildChild, PreschoolEpidemicsFemaleGenetic VariationGenome, ViralGenotypeHumansMaleNicaraguaPhylogenyTravel

Identifiers

PMID30059496
PMCPMC6085065
OpenAlexW2886453194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.